Visualizing challenging data
In many clinical contexts, data can be highly complex—requiring thoughtful techniques to transform raw figures into meaningful insights. But what makes data challenging? Read more
Uploading materials to Veeva: factors that influence time and costs
Whether you work at a large or small pharma company, your organization almost certainly has a formalized review process for ensuring the non-promotional materials your medical affairs team uses are accurate, in line with local regulations, and free of content that poses unacceptable legal risks, such as lawsuits from competitors. Read more
How an agency’s grasp on approval processes can make or break your medical content
If you work in medical affairs, you know that legal, medical, and regulatory review is crucial for the materials your team uses, whether internally, in the field, or at medical congress booths. But what about the agencies you partner with? Do they understand your company’s review process? Read more
Why quality control is key in medical writing and scientific visual storytelling
Working in medical affairs in pharma, you probably have a baseline expectation that your agency partner will thoroughly proofread and run quality control (QC) on the materials they create for you. After all, you want clean copy, stylistic consistency, and easy readability in your slide decks, videos, infographics, and eLearning modules. Read more
Navigating the price range: Unraveling the factors behind visual storytelling solution costs
As a visual storytelling agency, we often face the question of cost when we receive a project briefing and create a proposal. It’s an understandable question. But the answer can vary greatly. In many cases, we first need to provide a price range, which naturally leads clients to wonder, “what do I get for the lower end, and what do I get for the higher end?” Read more
Transforming a live training session into a self-study tool for medical affairs
Training sessions are an essential aspect of any medical affairs team in a pharmaceutical or biotech company. They provide an opportunity for medical affairs professionals to learn about the latest developments, industry best practices, and new product launches. But face-to-face or online training sessions have some limitations. The most obvious: only those who participate on the day of the training session get to access the content. This means that all those who could not participate in the session, as well as new medical affairs professionals who join later, miss out on the valuable information. Read more
Can we get open files?
When you work with an agency on slide decks, illustrations, infographics, print materials, or videos, you probably want to use these assets for at least a few years and have them adapted for different markets or leverage them for other materials. That requires having what many people call “open files” or “source files.”
Medical booth animation that adds value
Animated videos run in almost every pharma congress booth, from 3D MoA and MoD videos, to 2D clinical study explainer videos. An effective congress booth video should first draw people to your booth. But keeping them there takes more than “just” eye-catching visuals.
Any video at your booth should be didactically powered for your target audience and the information you want to share with them. Read more
Understanding science – the difference between a graphic design agency and a visual storytelling agency
The pharmaceutical industry is one of the most complex and highly regulated industries in the world. So, to communicate effectively with stakeholders like patients and doctors, it’s important that the message comes across clearly and accurately. We want to set the record straight and show what a graphic design agency and a visual storytelling agency can do for the pharmaceutical industry and which partner understands the science behind your products best. Read more
Educating or impressing? For the right effect, choose the right visual approach
Working in pharma, you use visual aids every day to talk about the latest developments in medical science. Maybe you’re explaining a disease’s pathophysiology and potential therapeutic targets to a physician. Maybe you’re presenting a new therapeutic’s mechanism of action to a group of key opinion leaders. Or maybe you’re training your MSLs to share the results of a recently published phase III trial. Read more